Overview
The ATCvet QD category covers dermatologicals. Within the EMA Union Product Database (medicines-output-medicines-report, dataset generated 20/07/2026), the QD-classified veterinary products include a topical corticosteroid for dogs and several ectoparasiticides (flea/tick products) classified under QP. This entry focuses on the QD dermatology and QD-adjacent topical ectoparasiticides relevant to pet species.
QD Dermatological Products
Pruban (resocortol butyrate) — EMEA/V/C/000048
- ATCvet code: QD07AC90
- INN: Resocortol butyrate (INN: resocortol butyrate)
- Active substance: resocortol butyrate
- Species: Dogs
- Status: Withdrawn
- Pharmacotherapeutic group: Corticosteroids, dermatological preparations
- Therapeutic indication: Treatment of acute localised moist dermatitis (hot spots) in dogs
- Marketing authorisation holder: Intervet International BV
Ectoparasiticides for Dogs and Cats (QP — Adjacent)
Although classified under QP (antiparasitic products), the following are topical insecticides directly relevant to dermatological health of pets:
Comfortis (spinosad) — EMEA/V/C/002233
- ATCvet code: QP53BX03
- INN: Spinosad (INN: spinosad)
- Active substance: spinosad
- Species: Dogs;Cats
- Status: Withdrawn
- Pharmacotherapeutic group: Other ectoparasiticides for systemic use
- Therapeutic indication: Treatment and prevention of flea infestations (*Ctenocephalides felis*). The preventive effect against re-infestations is maintained for 4 weeks.
- Marketing authorisation holder: Elanco GmbH
Activyl Tick Plus (indoxacarb;permethrin) — EMEA/V/C/002234
- ATCvet code: QP53AC54
- INN: Indoxacarb;Permethrin (INN: indoxacarb; permethrin)
- Active substance: indoxacarb; permethrin
- Species: Dogs
- Status: Withdrawn
- Pharmacotherapeutic group: Ectoparasiticides for topical use, incl. insecticides
- Therapeutic indication: Treatment of flea infestations (*Ctenocephalides felis*); the product has persistent insecticidal efficacy for up to 4 weeks against ticks.
- Marketing authorisation holder: Intervet International BV
ProMeris (metaflumizone) — EMEA/V/C/000107
- ATCvet code: QP53AX25
- INN: Metaflumizone (INN: metaflumizone)
- Active substance: metaflumizone
- Species: Cats
- Status: Withdrawn
- Pharmacotherapeutic group: Ectoparasiticides for topical use, incl. insecticides
- Therapeutic indication: Treatment and prevention of flea infestations (*Ctenocephalides canis* and *C. felis*) in cats.
- Marketing authorisation holder: Pfizer Limited
ProMeris Duo (metaflumizone;amitraz) — EMEA/V/C/000108
- ATCvet code: QP53AD51
- INN: Metaflumizone;Amitraz (INN: metaflumizone; amitraz)
- Active substance: metaflumizone; amitraz
- Species: Dogs
- Status: Withdrawn
- Pharmacotherapeutic group: Ectoparasiticides for topical use, incl. insecticides
- Therapeutic indication: For the treatment and prevention of infestations by fleas (*Ctenocephalides canis* and *C. felis*), and ticks (*Ixodes ricinus*, *Dermacentor reticulatus*, *Rhipicephalus sanguineus*) in dogs.
- Marketing authorisation holder: Pfizer Limited
Certifect (fipronil/amitraz/(S)-methoprene) — EMEA/V/C/002002
- ATCvet code: QP53AX65
- INN: Fipronil / Amitraz / (S)-Methoprene (INN: fipronil; amitraz; (S)-methoprene)
- Active substance: fipronil; amitraz; (S)-methoprene
- Species: Dogs
- Status: Withdrawn
- Pharmacotherapeutic group: Ectoparasiticides for topical use, incl. insecticides
- Therapeutic indication: Treatment and prevention of infestations in dogs by ticks (*Ixodes ricinus*, *Dermacentor reticulatus*, *Rhipicephalus sanguineus*) and fleas (*Ctenocephalides* spp.).
- Marketing authorisation holder: Merial
Cheristin — EMEA/V/C/004316
- ATCvet code: QP53AX
- Species: Cats
- Status: Application withdrawn
- Therapeutic indication: For the treatment and prevention of flea infestations (*Ctenocephalides felis*) on cats.
- Marketing authorisation holder: Elanco Europe Ltd
Key Facts
- QD07AC90 = resocortol butyrate — topical corticosteroid for acute localized moist dermatitis (hot spots) in dogs; MA holder Intervet International BV (EMEA/V/C/000048, Withdrawn).
- QP53BX03 = spinosad — systemic oral flea adulticide for dogs and cats; UK/CETMART brand Comfortis; Withdrawn.
- QP53AC54 = indoxacarb + permethrin — combination topical flea/tick product for dogs; Withdrawn.
- QP53AX65 = fipronil + amitraz + (S)-methoprene — triple-action topical ectoparasiticide for dogs; Withdrawn.
- All pet topical ectoparasiticides in the EMA database carry Withdrawn or Application withdrawn status, indicating these products are no longer marketed under their EMA MA numbers.
Source: EMA medicines-output-medicines-report_en.xlsx, dataset generated 20/07/2026 - 18:00, accessed via https://www.ema.europa.eu/en/medicines/download-medicine-data.